Active, not recruitingNCT06170671

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

Studying B-cell chronic lymphocytic leukemia

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: AstraZeneca
Intervention: Non interventional study(drug)
Enrollment: 250 target
Eligibility: 18-130 years · All sexes
Timeline: 2023 – 2028

Study locations (14)

Research Site, Piteşti, Argeş, Romania
Research Site, Oradea, Bihor County, Romania
Research Site, Cluj-Napoca, Cluj, Romania
Research Site, Craiova, Dolj, Romania
Research Site, Deva, Hunedoara County, Romania
Research Site, Baia Mare, Maramureş, Romania
Research Site, Târgu Mureş, Mureș County, Romania
Research Site, Piatra Neamţ, Neamț County, Romania
Research Site, Timișoara, Timiș County, Romania
Research Site, Focşani, Vrancea, Romania
Research Site, Brasov, Romania
Research Site, Bucharest, Romania
Research Site, Galati, Romania
Research Site, Iași, Romania

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06170671 on ClinicalTrials.gov

Other trials for B-cell chronic lymphocytic leukemia

Additional recruiting or active studies for the same condition.

See all trials for B-cell chronic lymphocytic leukemia →

← Back to all trials